Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Emcure PharmaceuticalsNSE:EMCURE -0.51%41 Forward Dividend Yield % is 0.19% as of Sep. 02, 2026. GuruFocus rates NSE:EMCURE with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 505 Drug Manufacturers companies, Emcure Pharmaceuticals ranks worse than 94.46% on this metric.
As of today (2026-09-02), the Forward Annual Dividend Yield of Emcure Pharmaceuticals is 0.19%.
As of today (2026-09-02), the Trailing Annual Dividend Yield of Emcure Pharmaceuticals is 0.16%.
NSE:EMCURE's Forward Dividend Yield % is ranked worse than 94.46% of 505
companies
in the Drug Manufacturers industry
Industry Median: 2.04
vs NSE:EMCURE: 0.19
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Emcure Pharmaceuticals Forward Dividend Yield % Related Terms
NSE:EMCURE vs ZTS: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Emcure Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emcure Pharmaceuticals Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Emcure Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Emcure Pharmaceuticals's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.19% mean?
Emcure Pharmaceuticals (NSE:EMCURE) has a Forward Dividend Yield % of 0.19% as of Sep. 02, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Emcure Pharmaceuticals and its competitors. According to the industry distribution chart, Emcure Pharmaceuticals ranks #477 out of 505 companies in the Drug Manufacturers industry, placing it in the top 94.5%.
Is Emcure Pharmaceuticals' Forward Dividend Yield % too high?
Emcure Pharmaceuticals' current Forward Dividend Yield % is 0.19%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.04. Emcure Pharmaceuticals' value of 0.19% is 90.7% below this industry median. Based on the distribution chart, Emcure Pharmaceuticals ranks #477 out of 505 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Emcure Pharmaceuticals has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Emcure Pharmaceuticals' Forward Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Emcure Pharmaceuticals ranks #477 out of 505 companies for Forward Dividend Yield %. This places Emcure Pharmaceuticals in the lower half of its industry. The industry median Forward Dividend Yield % is 2.04. Emcure Pharmaceuticals' value of 0.19% is 90.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.04, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Emcure Pharmaceuticals's current Forward Dividend Yield % of 0.19% is 90.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Emcure Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Emcure Pharmaceuticals's current Forward Dividend Yield % is 0.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emcure Pharmaceuticals stock overvalued right now?
Emcure Pharmaceuticals (NSE:EMCURE) has a current Forward Dividend Yield % of 0.19%. The current Forward Dividend Yield % is 0.19% and 90.7% below the Drug Manufacturers industry median of 2.04. Emcure Pharmaceuticals' overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Emcure Pharmaceuticals (NSE:EMCURE), the current Forward Dividend Yield % is 0.19% as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics. The company operates in Derma, Women's Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives. Geographically, it operates in India, Europe, Canada, Vietnam, Dubai, and Other Countries.
41GF Score
Get the complete analysis for NSE:EMCURE
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:EMCURE has been successfully added to your 
